KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Return on Assets (2016 - 2025)

CRISPR Therapeutics AG (CRSP) has disclosed Return on Assets for 10 consecutive years, with 0.27% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 9.0% to 0.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.27% through Dec 2025, down 9.0% year-over-year, with the annual reading at 0.27% for FY2025, 9.0% down from the prior year.
  • Return on Assets hit 0.27% in Q4 2025 for CRISPR Therapeutics AG, down from 0.25% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.33% in Q2 2021 to a low of 0.44% in Q3 2022.
  • Historically, Return on Assets has averaged 0.13% across 5 years, with a median of 0.17% in 2024.
  • Biggest five-year swings in Return on Assets: soared 44bps in 2021 and later tumbled -73bps in 2022.
  • Year by year, Return on Assets stood at 0.0% in 2021, then tumbled by -17912bps to 0.28% in 2022, then skyrocketed by 75bps to 0.07% in 2023, then plummeted by -155bps to 0.18% in 2024, then crashed by -50bps to 0.27% in 2025.
  • Business Quant data shows Return on Assets for CRSP at 0.27% in Q4 2025, 0.25% in Q3 2025, and 0.24% in Q2 2025.